Cite
Bosch M, de Lil HS, Oomen JJ, et al. Safety and efficacy of a Hb-triggered single-unit red cell transfusion policy for haemato-oncological inpatients. Br J Haematol. 2021;195(4):e154-e156doi: 10.1111/bjh.17748.
Bosch, M., de Lil, H. S., Oomen, J. J., Eijsink, C., Blijlevens, N. M. A., Hoeks, M. P. A., & Evers, D. (2021). Safety and efficacy of a Hb-triggered single-unit red cell transfusion policy for haemato-oncological inpatients. British journal of haematology, 195(4), e154-e156. https://doi.org/10.1111/bjh.17748
Bosch, Milou, et al. "Safety and efficacy of a Hb-triggered single-unit red cell transfusion policy for haemato-oncological inpatients." British journal of haematology vol. 195,4 (2021): e154-e156. doi: https://doi.org/10.1111/bjh.17748
Bosch M, de Lil HS, Oomen JJ, Eijsink C, Blijlevens NMA, Hoeks MPA, Evers D. Safety and efficacy of a Hb-triggered single-unit red cell transfusion policy for haemato-oncological inpatients. Br J Haematol. 2021 Nov;195(4):e154-e156. doi: 10.1111/bjh.17748. Epub 2021 Aug 05. PMID: 34355394.
Copy
Download .nbib